This global consulting and advisory services firm recently picked up a 4-year task with the Food and Drug Administration Center for Drug Evaluation and Research to provide a range of Business Intelligence and Publishing support services to this center charged with regulating over-the-counter and prescription drugs, including biological therapeutics and generic drugs.

The post FDA awards 29M CDER Business Intelligence and Publishing Support task to Deloitte appeared first on G2Xchange Health.



Please enter your comment!
Please enter your name here